Friday, 17 July 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 17 July 2026
Ascott 2
Ascott 2
Who's the new Novartis Country Head?

One of the biggest names in industry has been appointed the next Novartis Country President ANZ after leaving the top job at a rival company this year. 

Ali Rossiter lands new appointment
Exactly a month after resigning from her role as Novartis ANZ boss, Rossiter says this company's work is 'personally significant'
TODAY
MS drugs delisting threat ends
But it comes with a sting in the tail. The PBAC will launch a review of how the drugs are being used on the PBS to be concluded by December
TODAY
Medscape
Medscape
Who owns the next blockbuster?
The current top-valued R&D programs could rake in combined global sales of US$50M in 2032, if successfully launched
16 July
Roche GM's tough line on Aussie TV
Roche Australia's General Manager Nic Horridge has branded a Govt-requested price cut as unrealistic and unreasonable on ABC TV
15 July
Who's on the highest paid Aussie CEO list?
CEOs spanning biotech, medtech, and pharma distribution are among the highest-paid ASX-listed CEOs, a new report shows
15 July
Aussie lands international role
A promotion plus and airline ticket for this executive who has landed a top gig based in the company's office in Greece
15 July
Swipe/NEXT
Swipe/NEXT
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (23)

Access & Reimbursement (1)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (3)

Other (12)

Ex-Bayer boss joins Astellas
While a GM is yet to be announced, a Head of Sales has been named becoming the newest member of the Australian Leadership Team
TODAY
Aussie-first manufacturing facility opens
The opening of the new facility improves Australia's sovereign manufacturing capability and will reduce development time for radiopharmaceuticals
16 July
$100K fine over prescription drug
A pharmacy has been fined by the TGA less than six months after it issued a warning on illegal imports of a prescription drug
16 July
Aussie deal struck on biosimilar
Two pharmas have signed an agreement to commercialise a biosim, which may see a drug move closer to a PBS listing
16 July
Next on NEXT: A drug's life
The Summit will undertake something no pharma event in Australia has ever done before, putting industry in the driver's seat
16 July
Manufacturer and biotech team up
Sydney's Viral Vector Manufacturing Facility to collaborate on development of a gene therapy to restore sight
15 July
Inside MA's kids cancer roundtable
Roundtable discussions convened in partnership with the Children's Cancer Institute will contribute to a white paper
15 July
Is the Pharma Rep dead? No way
After much speculation that the pharma rep is 'dead' a survey of Australian doctors shows it's certainly not over yet for field teams
14 July
Wave of rare disease drugs hit TGA
These pharmas have less than six months to file their drugs and reap the benefits of the TGA's pathway
14 July
Novo serves a branding ace
In a high-profile campaign, 30 players at Wimbledon wore Novo branding on their shirts, delivering a major boost to the company's visibility
14 July
Who's bested two Big Pharmas?
Swedish rare disease specialist beat out giants Roche and Novo Nordisk to be named the best by this cohort of patients
14 July
Shortage of chemo drugs extended
Pharma notifies TGA that shortages of its chemotherapies, which started in March are set to continue, some until mid-December
14 July
PiF Advertise
PiF Advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.